197 related articles for article (PubMed ID: 19965666)
1. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.
Suryani S; Fulcher DA; Santner-Nanan B; Nanan R; Wong M; Shaw PJ; Gibson J; Williams A; Tangye SG
Blood; 2010 Jan; 115(3):519-29. PubMed ID: 19965666
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the regulatory role of BAFF in controlling the expression of CD21 and CD23.
Debnath I; Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2007 Mar; 44(9):2388-99. PubMed ID: 17140663
[TBL] [Abstract][Full Text] [Related]
3. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling.
Rowland SL; Leahy KF; Halverson R; Torres RM; Pelanda R
J Immunol; 2010 Oct; 185(8):4570-81. PubMed ID: 20861359
[TBL] [Abstract][Full Text] [Related]
4. Somatically diversified and proliferating transitional B cells: implications for peripheral B cell homeostasis.
Yeramilli VA; Knight KL
J Immunol; 2011 Jun; 186(11):6437-44. PubMed ID: 21525392
[TBL] [Abstract][Full Text] [Related]
5. Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells.
Taylor RL; Cruickshank MN; Karimi M; Ng HL; Quail E; Kaufman KM; Harley JB; Abraham LJ; Tsao BP; Boackle SA; Ulgiati D
Cell Mol Immunol; 2016 Jan; 13(1):119-31. PubMed ID: 25640655
[TBL] [Abstract][Full Text] [Related]
6. IRF4 Has a Unique Role in Early B Cell Development and Acts Prior to CD21 Expression to Control Marginal Zone B Cell Numbers.
Ottens K; Satterthwaite AB
Front Immunol; 2021; 12():779085. PubMed ID: 34880871
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function.
Gorelik L; Cutler AH; Thill G; Miklasz SD; Shea DE; Ambrose C; Bixler SA; Su L; Scott ML; Kalled SL
J Immunol; 2004 Jan; 172(2):762-6. PubMed ID: 14707045
[TBL] [Abstract][Full Text] [Related]
8. CD21(-/low) B cells in human blood are memory cells.
Thorarinsdottir K; Camponeschi A; Cavallini N; Grimsholm O; Jacobsson L; Gjertsson I; Mårtensson IL
Clin Exp Immunol; 2016 Aug; 185(2):252-62. PubMed ID: 27010233
[TBL] [Abstract][Full Text] [Related]
9. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.
Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P
Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883
[TBL] [Abstract][Full Text] [Related]
10. Different anti-CD21 antibodies can be used to discriminate developmentally and functionally different subsets of B lymphocytes in circulation of pigs.
Sinkora M; Stepanova K; Sinkorova J
Dev Comp Immunol; 2013 Apr; 39(4):409-18. PubMed ID: 23178404
[TBL] [Abstract][Full Text] [Related]
11. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes.
Debnath I; Roundy KM; Weis JJ; Weis JH
J Immunol; 2007 Jun; 178(11):7139-50. PubMed ID: 17513763
[TBL] [Abstract][Full Text] [Related]
12. B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10.
Strom AC; Cross AJ; Cole JE; Blair PA; Leib C; Goddard ME; Rosser EC; Park I; Hultgårdh Nilsson A; Nilsson J; Mauri C; Monaco C
Thromb Haemost; 2015 Oct; 114(4):835-47. PubMed ID: 26063196
[TBL] [Abstract][Full Text] [Related]
13. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM
J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142
[TBL] [Abstract][Full Text] [Related]
14. Novel human transitional B cell populations revealed by B cell depletion therapy.
Palanichamy A; Barnard J; Zheng B; Owen T; Quach T; Wei C; Looney RJ; Sanz I; Anolik JH
J Immunol; 2009 May; 182(10):5982-93. PubMed ID: 19414749
[TBL] [Abstract][Full Text] [Related]
15. Multiparameter analysis of human B lymphocytes identifies heterogeneous CD19
Wilfong EM; Vowell KN; Crofford LJ; Kendall PL
Cytometry A; 2023 Apr; 103(4):283-294. PubMed ID: 36281747
[TBL] [Abstract][Full Text] [Related]
16. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.
Isnardi I; Ng YS; Menard L; Meyers G; Saadoun D; Srdanovic I; Samuels J; Berman J; Buckner JH; Cunningham-Rundles C; Meffre E
Blood; 2010 Jun; 115(24):5026-36. PubMed ID: 20231422
[TBL] [Abstract][Full Text] [Related]
17. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development.
Su TT; Rawlings DJ
J Immunol; 2002 Mar; 168(5):2101-10. PubMed ID: 11859095
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lymphocyte subsets in patients with common variable immunodeficiency reveals subsets of naive human B cells marked by CD24 expression.
Vlková M; Fronková E; Kanderová V; Janda A; Ruzicková S; Litzman J; Sedivá A; Kalina T
J Immunol; 2010 Dec; 185(11):6431-8. PubMed ID: 21041728
[TBL] [Abstract][Full Text] [Related]
19. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity.
Terrier B; Joly F; Vazquez T; Benech P; Rosenzwajg M; Carpentier W; Garrido M; Ghillani-Dalbin P; Klatzmann D; Cacoub P; Saadoun D
J Immunol; 2011 Dec; 187(12):6550-63. PubMed ID: 22084433
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Signature of the CD24
Bigot J; Pilon C; Matignon M; Grondin C; Leibler C; Aissat A; Pirenne F; Cohen JL; Grimbert P
Am J Transplant; 2016 Dec; 16(12):3430-3442. PubMed ID: 27273606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
